An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem. After more than a year with the pandemic, although our knowledge has progressed on COVID-19, there are still many unknowns in virological, pathop...
Main Authors: | Bulent Kantarcioglu MD, Omer Iqbal MD, Jeanine M. Walenga PhD, Bruce Lewis MD, Joseph Lewis BS, Charles A. Carter BS, PharmD, MBA, Meharvan Singh PhD, Fabio Lievano MD, Alfonso Tafur MD, Eduardo Ramacciotti MD, PhD, Grigoris T. Gerotziafas MD, Walter Jeske PhD, Jawed Fareed PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296211021498 |
Similar Items
-
Porcine Mucosal Heparin Shortage Crisis! What Are the Options?
by: Jawed Fareed PhD, et al.
Published: (2019-09-01) -
Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-12-01) -
Arterial thrombotic complications in COVID-19 patients
by: Stef Levolger, MD, PhD, et al.
Published: (2020-09-01) -
Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values
by: Fakiha Siddiqui BDS, et al.
Published: (2019-07-01) -
Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-01-01)